Status:
TERMINATED
Evaluation Ultrasound Elasticity/Tissue Strain-Hardening Imaging for Prostate Cancer Patients Undergoing Radical Prostatectomy
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Prostate Cancer
Eligibility:
MALE
Phase:
NA
Brief Summary
The primary objective is to perform a pilot trial evaluation of a novel prostate ultrasound imaging software utilizing tissue elasticity measurements to identify tumor foci among men who will undergo ...
Detailed Description
Study Imaging: As part of routine care, ultrasound scanning is commonly used to find the cancerous areas of the prostate before the prostate is surgically removed. The ultrasound images are in black,...
Eligibility Criteria
Inclusion
- Patients selected for radical prostatectomy (any technique) at MDACC
- Histologic diagnosis of prostate cancer, clinical stage cT1c-cT3b
- Serum prostate specific antigen less than 30 ng/ml.
- Any Gleason score
- Total prostate volume of 20-60 cc, measured by outside ultrasound or clinical examination at MDACC.
- Group 1: high volume disease. At least 3 positive cores containing cancer on one side of the prostate Group 2: low volume disease. Less than 50% tumor length in a single positive core on one side of the prostate
Exclusion
- Prior radiation therapy to the pelvis
- Prior hormonal therapy within 3 months (including LH/RH agonists, estrogens, testosterone receptor blockade, finasteride, dutasteride)
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00824902
Start Date
December 1 2008
End Date
November 1 2013
Last Update
January 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UT MD Anderson Cancer Center
Houston, Texas, United States, 77030